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UNIT A18.1MRI of the Pancreas
MRI provides comprehensive information on the full range of pancreatic diseases. We
employ a set protocol incorporating various types of sequences including transverse and
coronal data acquisitions, and with the routine use of intravenous gadolinium.
BASIC
PROTOCOL
IMAGING THE PANCREAS
The high signal-to-noise ratio (SNR) obtained at high field strength makes it possible to
image the pancreas during a single breath-hold sequence. The sequences described herein
are based on the authors’ experience with a Siemens 1.5 T Vision scanner, but are expected
to be equally applicable to machines from other manufacturers.
Scanning a patient or volunteer is a joint effort among technologists, nurses, and
physicians, with the technologist normally responsible for following proper scanning
protocols and techniques. Unless otherwise specified, in what follows, the person to whom
directions are given is assumed to be the technologist. Table A18.1.1 lists the hardware
necessary to perform the procedure, along with appropriate parameters.
The following ten sequences comprise the pancreatic imaging protocol. Most sequences
require the patient to be able to suspend respiration for ∼20 sec. It is imperative that there
be clear communication between the technologist and the patient throughout the exam.
This protocol results in consistent, reproducible image quality that is effective for
evaluating the full spectrum of pancreatic diseases.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Materials
Normal saline (0.9% NaCl), sterile, 40 ml minimum
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance), volume
prescribed by patient weight
Set up equipment and patient
1. Interview (screen) the patient to assess for contraindications such as cardiac pace-
maker, implanted mechanical devices, and/or ferromagnetic materials. Also, deter-
mine if the patient has any health conditions that may require the presence of special
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Table A18.1.1 Equipment Specifications: Imaging of the Pancreas
Coil type Circularly polarized body phased array coil
Manufacturer and system type Siemens Vision
Field strength 1.5 T
Gradient strength 24 mT/ m (or whatever the system permits,
but minimum of 24 mg/m for sequences 3
and 4)
Knee cushion Yes
Use of contrast agents Yes
Pulse oximeter If patient requires sedation
Power injector Yes
Normal saline Yes
35-in. extension tubing Yes
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emergency equipment during the scanning procedure, or if he or she will need
sedation medication necessitating the use of appropriate monitoring equipment.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain X rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. Request that the patient change into a gown to eliminate any metal that might be found
in clothing. Ask the patient to remove all personal effects such as, jewelry, hearing
aids, glasses, etc., prior to entering the MRI scan room.
All personal belongings should be secured during the examination.
3. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected and ask them if they have any questions;
answer appropriately. If the procedure is a research protocol, have the patient sign
any necessary consent form.
4. Fill a 20-ml syringe with normal saline and attach to saline filled extension tubing
(35-in.). Obtain intravenous (i.v.) access utilizing a 22-G angiocatheter and attach
saline-prepared extension tubing and syringe. This will allow you to flush the
extension tubing while the patient waits to be imaged, and, in cases in which a power
injector is not available, this will allow preparation for bolus injection (see Note
below). Secure the position of the angiocatheter with tegraderm or tape.
Obtaining i.v. access prior to entering the scan room will promote patient throughput and
eliminate “dead” time of starting the i.v. while the patient is on the exam table. Follow
power injector manufacturer guidelines with regard to appropriate gauge needle/angio-
catheter to be used; this will depend on chosen injection/flow rates.
NOTE: If you do not have access to a power injector, you will still be able to perform
dynamic imaging as the extension tubing will allow the saline syringe to be placed at the
foot of the patient table during pre-contrast imaging. In this case, you will need to draw
up the contrast agent in another syringe. When you are ready to bolus inject the contrast
agent, simply disconnect the saline syringe and connect the syringe filled with contrast
agent; once you have injected the bolus of contrast agent, reconnect the saline syringe and
bolus an appropriate volume of flush, usually ∼10 ml. Alternatively, to eliminate the need
of switching syringes, incorporate the use of a 3-way stopcock.
5. Set up the exam room by securing the circularly polarized (CP)-body array coil onto
the table and providing a clean exam table.
6. Set up the power injector as specified by the manufacturer.
A minimum of 40 ml normal saline should be drawn up to ensure sufficient saline is
available to keep the vein open (KVO) throughout the exam. To determine the amount of
contrast agent to be used, reference the contrast agent packet insert and draw up the amount
indicated per kg of patient weight. There is no need to double dose.
7. Escort the patient to the MR examination room and ask the patient to lie down
accordingly with respect to the exam to be performed. Help the patient mount onto
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the table. Either before or right after the patient lies down, set up any triggering
devices or other monitoring equipment that is to be used.
8. Connect the extension tubing secured to the syringe to the power injector extension
tubing.
9. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case. Explain to the patient
that one should not reposition one’s body between imaging sequences.
Additionally, review breath-holding instructions with the patient, and provide the patient
with an approximate time that the examination will take.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
e. Position a support under the patient’s knees to enhance patient comfort.
10. Secure the top portion of the CP-body array coil to prevent it from moving side-to-side
during breath-holding imaging sequences.
Usually straps are provided by the manufacturer that are directly attached to the coil.
11. Use the laser light to position the patient, and to center the coil (see Table A18.1.2).
Then advance the patient table to isocenter.
12.  If the patient is unable to hold still, provide an appropriate sedative.
13. Program the power injector for a contrast agent and saline injection rate of 2 ml/sec.
Total volume of saline following contrast agent injection should be programmed for
10 ml. Program a scan delay of 18 sec (contrast agent is injected, scan is initiated 18
sec after contrast agent and saline are delivered). Arm the power injector and keep
the vein open.
Do not inject the contrast agent at this time!
Sequence 1: Three-plane positioning scout
14. To validate the patient’s position and to have a reference to prescribe successive
imaging sequences, acquire a three-plane orthogonal scout sequence. See Table
A18.1.2 for specific parameters.
Most MR scanners can be programmed to acquire the scout automatically after coil tuning
or after the patient has been placed in isocenter (for systems that do not require tuning).
Sequence 2: Breath-hold three—plane positioning scout
15. To have a reference to prescribe successive breath-hold imaging sequences, acquire
a second three-plane orthogonal scout sequence. See Table A18.1.2 for specific
parameters.
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16. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
17. Initiate the scan.
Sequence 3: Half-acquisition (partial Fourier) turbo spin echo coronal
18. Display both the coronal and transverse scout images (use non-breath-hold images)
in two separate quadrants on the scan monitor. Change imaging parameters to those
listed in Table A18.1.3. Position slices to center of the transverse scout, ensuring that
the pancreas and liver are covered.
19. Instruct the patient to remain motionless and to breathe normally as the scan will
begin and last for ∼40 sec.
Sequence 4: Half-acquisition turbo spin echo transverse (Fig. A18.1.1)
20. Display both the coronal and transverse scout images (use non-breath-hold images)
in two separate quadrants on the scan monitor. Change imaging parameters to those
listed in Table A18.1.4. Position slices to center of the coronal scout, ensuring that
the pancreas and liver are entirely covered.
21. Instruct the patient to remain motionless and to breathe normally as the scan will
begin and last for ∼40 sec.
Sequence 5: Transverse gradient echo with fat saturation (fat suppression) (Fig.
A18.1.2)
22. Display both the coronal and transverse scout images (use breath-hold images) in
two separate quadrants on the scan monitor. Change imaging parameters to those
listed in Table A18.1.5. Position slices to center of the coronal scout, ensuring that
the pancreas is entirely covered.
Table A18.1.2 Imaging Parameters for Scout Sequence (Sequences 1 and 2)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal, transverse, and coronal
Central slice or volume center Laser light centered
approximately one hand width
above the inferior rib margin
Echo time (TE) 6 msec
Repeat time (TR) 15 msec
Flip angle (FA) 30°
Field of view (FOVx, FOVy) 450 mm, 450 mm
Resolution (∆x, ∆y) 1.76 mm, 3.52 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 3
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Not applicable
Saturation pulse Not applicable
Scan time 16 sec
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It is imperative that the slices are prescribed off of the breath-hold scout images as this is
a breath-held imaging sequence. Otherwise, the slice location will not be accurate relative
to the reference image if a non-breath-held image is used.
23. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
24. Initiate the scan.
Figure A18.1.1 Unenhanced transverse half-acquisition turbo spin echo image.
Table A18.1.3 Imaging Parameters for Half-Acquisition Turbo Spin Echo
(Sequence 3)
Patient position Supine
Scan type Half-acquisition turbo spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Slices posted on transverse scout;
center to pancreas
Echo time (TE) 90 msec
Repeat time (TR) 4.4 msec (note: The true TR is
infinite; 4.4 msec represents the
echo spacing)
Delay time (TD) 1500 msec
Flip angle (FA) 150°
Fields of view (FOVx FOVy) 400 mm, 400 mm
Resolution (∆x ∆y) 1.56 mm, 2.08 mm
Number of data points collected (Nx, Ny) 256, 192 (using half Fourier)
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover the pancreas
and liver
Saturation pulses No
Slice series Interleaved
Scan time 40 sec
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Table A18.1.4 Imaging Parameters for Half-Acquisition Turbo Spin Echo
(Sequence 4)
Patient position Supine
Scan type Half-acquisition turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
pancreas
Echo time (TE) 90 msec
Repeat time (TR) 4.4 msec (note: The true TR is
infinite; 4.4 msec represents the
echo spacing)
Delay time (TD) 1500 msec
Flip angle (FA) 150°
Fields of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37mm, 1.37 mm
Number of data points collected (Nx, Ny) 256, 192 (using half Fourier)
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover the pancreas
and liver
Saturation pulses Yes, superior and inferior to slices
Fat suppression No
Slice series Interleaved
Scan time 40 sec
Figure A18.1.2 Unenhanced fat suppressed transverse spoiled gradient echo
image.
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Sequence 6: Transverse gradient echo (out-of-phase) (Fig. A18.1.3)
25. Display the coronal and transverse breath-hold scout images (sequence 2) in two
separate quadrants on the scan monitor. Change imaging parameters to those listed
in Table A18.1.6. Position slices to cover the pancreas and liver.
It is imperative that the slices bee prescribed off of the breath-hold coronal scout as this is
a breath-held imaging sequence. Otherwise, the slice location will not be accurate relative
to the reference image if a non-breath-held image is used.
Table A18.1.5 Imaging Parameters for Gradient Echo with Fat Saturation
(Sequence 5)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
pancreas
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Fields of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05 mm
Number of data points collected
(Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 6 mm
Number of slices 20
Slice gap 1.2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover the pancreas
Saturation pulses No
Fat suppression Yes
Slice series Interleaved
Scan time 19 sec
Figure A18.1.3 Out-of-phase transverse spoiled gradient echo image.
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26. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
27. Initiate the scan.
Sequence 7: Transverse gradient echo (Fig. A18.1.4)
28. Display the breath-hold coronal and transverse scout images (sequence 2) in two
separate quadrants on the scan monitor. Change imaging parameters to those listed
in Table A18.1.7. Position slices to cover the pancreas and liver.
Table A18.1.6 Imaging Parameters for Gradient Echo—Out-of-Phase
(Sequence 6)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
the pancreas
Echo time (TE) 2.2 msec
Repeat Time (TR) 140 msec
Flip angle (FA) 80°
Fields of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1. 37 mm, 2.05 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover the pancreas
and liver
Saturation pulses No
Slice series Interleaved
Scan time 19 sec
Figure A18.1.4 Unenhanced transverse spoiled gradient echo image.
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It is imperative that the slices are prescribed off of the breath-hold coronal scout image as
this is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
29. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
30. Initiate the scan.
Sequence 8: Transverse gradient echo—Immediate postcontrast (Fig. A18.1.5)
NOTE: See patient set up section for specific instructions on preparation for contrast
injection. This preparation must be done prior to placing the patient in the scanner.
31. Repeat step 28.
It is imperative that the slices be prescribed off of the breath-hold coronal scout image as
this is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
32. Explain to the patient that you will now be injecting the contrast agent and he/she
may feel a cool sensation in his/her arm. Initiate the injection. Do not begin scanning
until the 18 sec scan delay has expired. However, deliver breathing instructions when
10 sec of delay are remaining (see step 33).
If you do not have access to a power injector and are “hand” injecting, you can still use
step 32. However, after you have completed the bolus contrast injection, reattach the
saline-filled syringe and flush with 10 ml of saline. Begin breathing instructions after 5 ml
of the saline has been injected, then proceed to initiate the scan. The process of switching
syringes must be completed as quickly as possible and thus it is suggested that a 3-way
stopcock be incorporated.
Table A18.1.7 Imaging Parameters for Gradient Echo (Sequence 7)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
the pancreas
Echo time (TE) 4.1 msec
Repeat time (TR) 140 msec
Flip angle (FA) 80°
Fields of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 18
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover the pancreas
and liver
Saturation pulses No
Slice series Interleaved
Scan time 18 sec
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33. When there are 10 sec of delay remaining, instruct the patient to take in a deep breath
and exhale, take in another deep breath and hold it.
34. Initiate the scan.
Sequence 9: Transverse gradient echo—45 sec delay after sequence 8
35. Repeat step 28.
36. Once 45 sec has expired, instruct the patient to take in a deep breath and exhale, take
in another deep breath and hold it.
37. Initiate the scan.
Sequence 10: Transverse gradient echo with fat saturation (90 sec delay after
injection; Fig. A18.1.6)
38. Display the midline slice of the breath-hold coronal and transverse scout images
(sequence 2) in two separate quadrants on the scan monitor. Change imaging
Figure A18.1.5 Immediate post contrast transverse spoiled gradient echo im-
age.
Figure A18.1.6 Post contrast fat suppressed transverse spoiled gradient echo
image. 
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parameters to those listed in Table A18.1.8. Position slices to cover the pancreas and
liver.
It is imperative that the slices are prescribed off of the gradient echo coronal image as this
is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
39. Once 90 sec has expired, instruct the patient to take in a deep breath and exhale, then
take in another deep breath and hold it.
40. Initiate the scan.
COMMENTARY
Background Information
MRI using a combination of non-contrast
T1-weighted fat suppressed imaging and imme-
diate post-gadolinium spoiled gradient echo
has been shown to be effective at exhibiting the
full range of pancreatic disease (Gabata et al.,
1994; Kelekis et al., 1995; Mitchell et al., 1995;
Semelka et al., 1991; Semelka and Ascher,
1993; Semelka et al., 1993a,b; Semelka et al.,
1996; Winston et al., 1995). Normal pancreas
enhances in a moderately intense, uniform
fashion on immediate post-gadolinium images,
reflecting a uniform network of capillary ves-
sels (Semelka et al., 1991; Semelka and Ascher,
1993). The normal pancreas is also moderately
intense on non-contrast T1-weighted fat sup-
pressed images due to the presence of aqueous
protein in the ascini of the glandular pancreas
(Mitchell et al., 1995; Semelka et al., 1991;
Semelka et al., 1993a; Winston et al., 1995).
Particular strengths of MRI include the detec-
tion of small ductal adenocarcinomas and islet
cell tumors (Gabata et al., 1994; Kelekis et al.,
1995; Semelka et al., 1991; Semelka et al.,
1993a,b; Semelka et al., 1996).
Critical Parameters and
Troubleshooting
The most important data acquisition is the
immediate post gadolinium spoiled gradient
Table A18.1.8 Imaging Parameters for Gradient Echo with Fat Saturation—90
Sec Delay (Sequence 10)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
the pancreas
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Fields of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 6 mm
Number of slices 20
Slice gap 1.2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover entire pancreas
and liver
Saturation pulses No
Fat suppression Yes
Slice series Interleaved
Scan time 19 sec
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echo sequence. The critical aspect of this se-
quence is that the timing of gadolinium must
be during the hepatic arterial dominant phase
(or capillary phase) of enhancement (Semelka
et al., 1993a). To ensure appropriate timing,
contrast should be present in the hepatic arteries
and portal veins and not yet present in the
hepatic veins (Semelka et al., 1993a). The pa-
tient must be able to breath-hold for 20 sec to
achieve optimal results for studying the pan-
creas, as required for the T1-weighted gradient
echo sequence.
Fat-suppressed spin echo (see Table
A18.1.9) can be substituted for the fat sup-
pressed spoiled gradient echo, if this latter se-
quence is not available on the scanner. Patients
who are unable to breathhold or breathe in a
regular fashion are better examined by CT
(computed tomography).
Anticipated Results
In a patient who can suspend respiration and
using an MR protocol that includes non-con-
trast T1-weighted fat suppressed spoiled gradi-
ent echo and immediate post contrast spoiled
gradient echo imaging, one can successfully
evaluate a full range of pancreatic diseases.
Particular strengths of this approach are in the
detection of small pancreatic ductal adenocar-
cinomas, ampullary tumors and islet cell tu-
mors, and staging of pancreatic neoplasms in
general.
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